Aim of this prospective trial is to assess the hemodynamic effects of a MitraClip procedure
caused iatrogenic arterial septal defect (iASD) and the functional changes after
interventional iASD closure in a randomized setting.
Device: Figulla Flex Occluder (Occlutech)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03024268
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Previous MitraClip implantation
Persistent relevant iASD 30 days after MitraClip intervention
Unsuccessful MitraClip implantation
No relevant iASD 30 days after MitraClip intervention
Unstable angina in the previous 4 weeks
Valvular heart disease (aortic, tricuspid or pulmonary valve) planed for surgery or
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.